Discover our commitment to authenticity, value, and speed for every beauty enthusiast
The combination of GLP-1 and GIP activation is what separates tirzepatide from pure GLP-1 agonists like semaglutide, and clinical data suggests the dual mechanism produces superior weight loss outcomes
Other possible risks include dizziness, fatigue, headache, stomach discomfort, bloating, indigestion, gas pains, and burping
Start your journey by booking a Root Cause Consultation
Anaheim, CA Elizabeth W
To our knowledge, no study assessed the potential of abuse of these medications anecdotally reported in anorexia or bulimia nervosa, which would require further investigation